AuBuchonJ.P., BirkmeyerJ.D., BuschM.P.. Safety of the blood supply in the United States: Opportunities and controversies.Ann Intern Med1997; 127: 904–9.
2.
American Medical Association.Council on Scientific Affairs. Autologous blood transfusion.JAMA1986; 256: 2378–80.
3.
SurgenorD.M.. The patient's blood is the safest blood (Editorial).New EngI J Med1987; 26: 542–4.
GoldfingerD., HaimowitzM.. Controversies in transfusion medicine. Is autologous blood transfusion worth the cost? Pro.Transfusion1994; 34: 75–8.
6.
AuBuchonJ.P., BirkmeyerJ.D.. Controversies in transfusion medicine. Is autologous blood transfusion worth the cost? Con.Transfusion1994; 34: 75–8.
7.
DoddR.Y.. Adverse consequences of blood transfusion: Quantitative risk estimates. In: NanceS.T., ed. Blood supply: risks, perceptions and prospects for the future.Bethesda: American Association of Blood Banks, 1994: 1–24.
8.
SchreiberG.B., BusshM.P., KIemmanS.H., KorelitzJ.J.. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.N EngI J Med1997; 334: 1685–90.
9.
MollisonP.L., EngelfrietC.P., ContrerasM.. Blood Transfusion in Clinical Medicine.Infectious agent transmitted by transfusion.Oxford, Blackwell Science1997; Ch 16, pp 509–557.
10.
WillR.G., KimberlinR.H.. Creutzfeld-Jakob disease and the risk from blood or blood products.Vox Sang1998; 75: 178–80.
11.
PoposkyM.. Transfusion reactions.Bethesda, MD, American Association of Blood Banks Press, 1996.
12.
KleinH.G.. Immunomodulation caused by blood transfusion. In: PetzL.D., SwisherS.N., KIemmanS.., eds Clinical practice of transfusion medicine.3rd edNew York: Churchill Livingstone, 1996: 59–69.
13.
BlajchmanM.A.. Allogeneic blood transfusions, Immunomodulation, and postoperative bacterial infection: Do we have the answer yet?Transfusion1997; 37: 121–5.
14.
ThomasM.J.G., DesmonM.J., GillonJ.. Consensus Conference on Autologous Transfusion. General background paper.Transfusion1996; 36: 628–32.
15.
SurgenorD.M., WallaceE.L., HaoS.H., ChapmanR.H.. Collection and transfusion of blood in the United States, 1982–1988.N EngI J Med1990; 332: 1646–51.
16.
GoodnoughL.T., ShafronD., MarcusR.E.. Impact of preoperative autologous blood donation in elective orthopaedic surgery.Vox Sang1990; 59: 65–9.
17.
National Heart, Lung and Blood Institute Panel on the use of Autologous Blood.Transfusion alert: use of autologous blood.Transfusion1995; 35: 703–11.
18.
AuBuchonJ.P., PopowskyM.A.. The safety of preoperative autologous blood donation in the nonhospital setting.Transfusion1991; 31: 513–7.
19.
McVayP.A., AndrewsA., KaplanE.B.. Donation reactions among autologous donors.Transfusion1990; 30: 249–52.
20.
PopovskyM.A., WhitakerB., ArnoldN.L.. Severe outcomes of allogeneic and autologous blood donation: Frequency and characterization.Transfusion1995; 35: 734–7.
21.
DzikW.H., FleisherA.G., CiavarellaD., KarlsonK.J., ReedG.E., BergerR.L.. Safety and efficacy of autologous blood donation before elective aortic valve operation.Ann Thorac Surg1992; 54: 1177–80.
22.
SpiessB.D., SassettiR., McCarthyR.J., NarboneR.F., TumanK.J., IvankovichA.D.. Autologous blood donation: hemodynamics in a high-risk patient population.Transfusion1992; 32: 17–22.
23.
GoodnoughL.T., SoegiarsoR.W., GehaA.S.. Blood lost and blood transfused in patients undergoing elective coronary artery bypass: Implications for blood conservation strategies.Surg Gynecol Obstet1993; 177: 345–51.
24.
SchmidtP.J.. Blood donation by the healthy elderly.Transfusion1991; 31: 681–3.
LindenJ.V., PaulB., DressIerK.P.. A report of 104 transfusion errors in New York State.Transfusion1992; 32: 601–6.
27.
MercurialiF., InghilleriG., ColottiM.T.. Bedside transfusion errors: Analysis of 2 years use of a system to monitor and prevent transfusion errors.Vox Sang1996; 70: 16–20.
28.
ForgieM.A., WellsP.S., LaupacisA., FergussonD.. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Preoperative Transfusion (ISPOT) Investigators.Arch Intern Med1998; 158: 610–6.
29.
MercurialiF., InghilleriG., BiffiE., VinciA., ColottiM.T., ScalamognaR.. Autologous blood predeposit and cell salvage in orthopedic surgery.Transfusion Med1993; 3(Suppl 1): S13.
30.
GoodnoughL.T., ShafronD., MarcusR.E.. Impact of preoperative autologous blood donation in elective orthopaedic surgery.Vox Sang1990; 59: 65–9.
31.
ToyPTCY, MenozziD., StraussR.G., StehungL.C.. Kruskall M, Ahn DK. Efficacy of preoperative donation of blood for autologous use in radical prostatectomy.Transfusion1993; 33: 721–4.
32.
GoodnoughL.T., SoegiarsoR.W., GehaA.S.. Blood lost and blood transfused in patients undergoing elective coronary artery bypass: Implications for blood conservation strategies.Surg Gynecol Obstet1993; 177: 345–51.
33.
GoodnoughL.T., VizmegK., VerbruggeD.. The impact of autologous blood ordering and blood procurement practices on allogeneic blood exposure in elective orthopedic surgery patients.Am J Clin Path1994; 101: 354–7.
CazzolaM., MercurialiF., BruganraC.. Use of recombinant human erythropoietin outside the setting of uremia.Blood1997; 12: 4248–67.
39.
KichlerT.S., SpivakJ.L.. Effect of repeated whole blood donations on serum immuno reactive erythropoietin levels in autologous donors.JAMA1988; 260: 65–7.
40.
GoodnoughL.T., BrittenhamG.. Limitations of the erythropoietic response to serial phlebotomy: Implications for autologous blood donor programs.J Lab Clin Med1990; 115: 28–32.
41.
GoodnoughL.T.. Erythropoietin as a farmacologic alternative to blood transfusion in the surgical patients.Transfusion Med Rev1990; 4: 288–296.
42.
LevineE.A., GouldS.A., RosenA.L.. Perioperative recombinant human erythropoietin.Surgery1989; 106: 432–8.
43.
FansP.M., RitterM.A., AbelsR.I.. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopedic operation. The American Erythropoietin Study Group.J Bone Joint Surg (Am)1996; 7: 62–72.
44.
MercurialiF., ZanellaA., BarosiG.. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients.Transfusion1993; 33: 55–60.
45.
MercurialiF., GualtieriG., SinigagliaL.. Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery.Transfusion1994; 34: 501–6.
46.
MercurialiF., lnghilleriG., BiffiE., ColottiM.T., VinciA., OrianiG.. Epoetin alfa in low hematocrit patients to facilitate autologous blood donation in total hip replacement: a randomized, double blind, placebo controlled dose ranging study.Acta Haematologica1998; 100: 69–76.
47.
PriceT.H., GoodnoughL.T., VoglerW.R.. The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double blind, controlled study.Transfusion1996; 36: 29–36.
EtchasonJ., PetzL., KeelerE.. The cost effectiveness of preoperative autologous blood donations.N EngI J Med1995; 332: 719–24.
50.
TretiakR., LaupacisA., RiviereM., McKerracherK., SouetreE.. Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study.CMAJ1996; 154: 1401–8.
51.
KruskallM.S., YomtovianR., DzikW.H., FriedmanK.D., UmlasJ.. On improving the cost-effectiveness of autologous blood transfusion practices.Transfusion1994; 34: 259–64.
52.
DzikW.H., DevarajanS.. Should autologous blood that tests positive for infectious diseases be used or discarded? A decision analysis approach.Transfusion1989; 29(8): 743–5.
53.
BaeleP.L., De BruyereM., DeneysV.. Bedside transfusion errors. A prospective survey by the Belgium SANGUIS group.Vox Sang1994; 66: 117–21.
54.
WenzB., MercurialiF., AuBuchonJ.P.. Practical methods to improve transfusion safety by using novel blood unit and patient identification systems.Am J Clin Pathol1997; 107(Suppl 1): S12–16.
55.
MercurialiF., InghilleriG.. Proposal of an algorithm to help the choice of the best transfusion strategy.Curr Med Res Opinion1996; 13: 465–78.
56.
GoodnoughL.T., PriceT.H., RudnickS., SoegiarsoR.W.. Preoperative red blood cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy.Transfusion1992; 32: 441–5.
57.
AxelrodF.B., PepkowitzS.H., GoldfingerD.. Establishment of a schedule of optimal preoperative collection of autologous blood.Transfusion1989; 29: 677–80.